The customer stated that they received questionable results for an unspecified number of patient samples tested for a1c-3 tina-quant hemoglobin a1c gen.3 (hba1c) on a cobas 6000 c (501) module - c501.Of the questioned samples, one patient sample had an erroneous hba1c result reported outside of the laboratory.The patient received treatment based on the erroneous result.The customer stated that the issue began when they started using a new reagent pack of the same lot number.No calibration was run on this new pack.Quality controls with an acceptable recovery were also not generated on the pack.The pack was on board the analyzer as a stand-by pack prior to being used.The sample initially resulted with an hba1c value of 6.8% and this value was reported outside of the laboratory.The sample was repeated, resulting as 5.3 %.The repeat result was believed to be correct.The patient received treatment for a diabetic protocol based on the erroneous result.The customer was asked, but could not provide any information on whether the patient was adversely affected due to this treatment.No adverse events were alleged to have occurred with the patient.The c501 analyzer serial number was (b)(4).The field application specialist was on site and instructed the customer to place a new reagent pack on board.The placed a new pack on board and ran controls.Controls passed and the customer did not encounter any further issues.The customer declined further service.
|